Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia

J Oury, W Zhang, N Leloup, A Koide, AD Corrado… - Nature, 2021 - nature.com
Congenital myasthenia (CM) is a devastating neuromuscular disease, and mutations in
DOK7, an adaptor protein that is crucial for forming and maintaining neuromuscular …

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7

J Hamuro, O Higuchi, K Okada, M Ueno… - Journal of biological …, 2008 - ASBMB
Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both
Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 …

Dok-7 mutations underlie a neuromuscular junction synaptopathy

D Beeson, O Higuchi, J Palace, J Cossins… - Science, 2006 - science.org
Congenital myasthenic syndromes (CMSs) are a group of inherited disorders of
neuromuscular transmission characterized by fatigable muscle weakness. One major …

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes

JS Müller, A Herczegfalvi, JJ Vilchez, J Colomer… - Brain, 2007 - academic.oup.com
Abstract Dok ('downstream-of-kinase') family of cytoplasmic proteins play a role in signalling
downstream of receptor and non-receptor phosphotyrosine kinases. Recently, a skeletal …

Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7

A Ben Ammar, F Petit, N Alexandri, K Gaudon… - Journal of …, 2010 - Springer
Congenital myasthenic syndromes (CMSs) are a heterogeneous group of diseases caused
by genetic defects affecting neuromuscular transmission. Mutations of DOK7 have recently …

The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization

E Bergamin, PT Hallock, SJ Burden, SR Hubbard - Molecular cell, 2010 - cell.com
Formation of the vertebrate neuromuscular junction requires, among others proteins, Agrin,
a neuronally derived ligand, and the following muscle proteins: LRP4, the receptor for Agrin; …

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome

J Cossins, WW Liu, K Belaya, S Maxwell… - Human molecular …, 2012 - academic.oup.com
Congenital myasthenic syndromes (CMS) are a group of inherited diseases that affect
synaptic transmission at the neuromuscular junction and result in fatiguable muscle …

A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient …

S Zhang, B Ohkawara, M Ito, Z Huang… - Human Molecular …, 2023 - academic.oup.com
At the neuromuscular junction, the downstream of tyrosine kinase 7 (DOK7) enhances the
phosphorylation of muscle-specific kinase (MuSK) and induces clustering of acetylcholine …

[HTML][HTML] Dok-7/MuSK signaling and a congenital myasthenic syndrome

Y Yamanashi, O Higuchi, D Beeson - Acta Myologica, 2008 - ncbi.nlm.nih.gov
Skeletal muscle contraction is controlled by motor neurons, which contact the muscle at the
neuromuscular junction (NMJ). The formation and maintenance of the NMJ, which includes …

DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction

S Arimura, T Okada, T Tezuka, T Chiyo, Y Kasahara… - Science, 2014 - science.org
The neuromuscular junction (NMJ) is the synapse between a motor neuron and skeletal
muscle. Defects in NMJ transmission cause muscle weakness, termed myasthenia. The …